Evidence map›Paper›PMID 38982267›Full record

ArticleScientific reports2024

Habitat radiomics and deep learning fusion nomogram to predict EGFR mutation status in stage I non-small cell lung cancer: a multicenter study.

Jingran Wu, Hao Meng, Lin Zhou, Meiling Wang, Shanxiu Jin, Hongjuan Ji, Bona Liu, Peng Jin, Cheng Du

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. The predictive value ofFrontiers in medicine · 2026
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jingran Wu *Department of Oncology, General Hospital of Northern Theater Command, Shenyang, 110840, China.
Hao Meng *Department of Thoracic Surgery, General Hospital of Northern Theater Command, Shenyang, 110840, China.
Lin Zhou *Department of Thoracic Surgery, Yuebei People's Hospital Affiliated to Shantou University Medical College, Shaoguan, 512025, China.
Meiling WangDepartment of Oncology, General Hospital of Northern Theater Command, Shenyang, 110840, China.
Shanxiu JinDepartment of Oncology, General Hospital of Northern Theater Command, Shenyang, 110840, China.
Hongjuan JiDepartment of Oncology, General Hospital of Northern Theater Command, Shenyang, 110840, China.
Bona Liu *Department of Oncology, General Hospital of Northern Theater Command, Shenyang, 110840, China. apbnaliu@sina.com.
Peng Jin *Department of Oncology, The Second Affiliated Hospital of Shandong First Medical University, Taian, 271000, China. 12196288@qq.com.
Cheng Du *Department of Oncology, General Hospital of Northern Theater Command, Shenyang, 110840, China. dc1115010@sina.com.

Funding

Liaoning Province Nature Science Foundation 2023JH2/101700101Shenyang Medical Engineering Cross Research Funds 22-321-32-09
6 · The paper itself

Abstract

Develop a radiomics nomogram that integrates deep learning, radiomics, and clinical variables to predict epidermal growth factor receptor (EGFR) mutation status in patients with stage I non-small cell lung cancer (NSCLC). We retrospectively included 438 patients who underwent curative surgery and completed driver-gene mutation tests for stage I NSCLC from four academic medical centers. Predictive models were established by extracting and analyzing radiomic features in intratumoral, peritumoral, and habitat regions of CT images to identify EGFR mutation status in stage I NSCLC. Additionally, three deep learning models based on the intratumoral region were constructed. A nomogram was developed by integrating representative radiomic signatures, deep learning, and clinical features. Model performance was assessed by calculating the area under the receiver operating characteristic (ROC) curve. The established habitat radiomics features demonstrated encouraging performance in discriminating between EGFR mutant and wild-type, with predictive ability superior to other single models (AUC 0.886, 0.812, and 0.790 for the training, validation, and external test sets, respectively). The radiomics-based nomogram exhibited excellent performance, achieving the highest AUC values of 0.917, 0.837, and 0.809 in the training, validation, and external test sets, respectively. Decision curve analysis (DCA) indicated that the nomogram provided a higher net benefit than other radiomics models, offering valuable information for treatment.

Indexed as

Carcinoma, Non-Small-Cell LungDeep LearningErbB ReceptorsLung NeoplasmsMutationNomogramsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm StagingRadiomicsRetrospective StudiesEGFR protein, humanErbB Receptors

Identifiers

PMID38982267
PMCPMC11233600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.